RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

218 hedge funds and large institutions have $4.35B invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 92 increasing their positions, 71 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
-3
Holders Change %
-1.36%
% of All Funds
3.49%
Holding in Top 10
13
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-23.53%
% of All Funds
0.21%
New
39
Increased
92
Reduced
71
Closed
39
Calls
$110M
Puts
$29.9M
Net Calls
+$79.8M
Net Calls Change
+$90M
Name Holding Trade Value Shares
Change
Shares
Change %
LCM
251
Landscape Capital Management
New Jersey
-$344K -3,128 Closed
HF
252
HRT Financial
New York
-$308K -2,806 Closed
BCM
253
Bayesian Capital Management
New York
-$242K -2,200 Closed
CL
254
CSS LLC
Illinois
-$165K -1,500 Closed
MCC
255
Money Concepts Capital
Florida
-$71.2K -647 Closed
SIM
256
Sandia Investment Management
Massachusetts
-$55K -500 Closed
Rockefeller Capital Management
257
Rockefeller Capital Management
New York
-$4K -39 Closed
CS
258
Comerica Securities
Michigan
-$660 -6 Closed